A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.

Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, ...

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

Individuals living with ALS are automatically eligible for Medicare when they start receiving Social Security benefits. Medicare should cover most diagnostics and treatments, but this depends on the ...

“This Orphan Drug Designation from the USFDA underlines the urgent need to develop Usnoflast to address Amyotrophic Lateral Sclerosis (ALS), which is a fatal neurodegenerative disease," said Zydus' ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

A third case of avian influenza has been detected in Ireland since the Minister for Agriculture introduced new strict biosecurity regulations for poultry on 6 December 2024. It comes as an Avian ...

a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS). Under the leadership of Principal Investigator Prof Merit Cudkowicz, MD, Director of the Sean M. Healey ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the Montreal Neurological Institute-Hospital. Dr. Olivier Blanchard and his team want ...